DK2117525T3 - Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte - Google Patents

Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte

Info

Publication number
DK2117525T3
DK2117525T3 DK08716394.5T DK08716394T DK2117525T3 DK 2117525 T3 DK2117525 T3 DK 2117525T3 DK 08716394 T DK08716394 T DK 08716394T DK 2117525 T3 DK2117525 T3 DK 2117525T3
Authority
DK
Denmark
Prior art keywords
dimethylamino
phenyl
treatment
neuropathic pain
propane compounds
Prior art date
Application number
DK08716394.5T
Other languages
Danish (da)
English (en)
Inventor
Thomas Christoph
Babette-Yvonne Koegel
Elmar Friderichs
Muriel Dr Meen
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39345501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2117525(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK2117525T3 publication Critical patent/DK2117525T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK08716394.5T 2007-03-12 2008-03-10 Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte DK2117525T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007012165A DE102007012165A1 (de) 2007-03-12 2007-03-12 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
PCT/EP2008/001884 WO2008110323A1 (de) 2007-03-12 2008-03-10 Verwendung von 1-phenyl-3-dimethylamino-propanverbindungen zur therapie des neuropathieschmerzes

Publications (1)

Publication Number Publication Date
DK2117525T3 true DK2117525T3 (da) 2014-02-03

Family

ID=39345501

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08716394.5T DK2117525T3 (da) 2007-03-12 2008-03-10 Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte

Country Status (13)

Country Link
US (2) US20080269326A1 (https=)
EP (1) EP2117525B1 (https=)
JP (5) JP2010520907A (https=)
CA (1) CA2680771C (https=)
CY (1) CY1115455T1 (https=)
DE (1) DE102007012165A1 (https=)
DK (1) DK2117525T3 (https=)
ES (1) ES2452830T3 (https=)
HR (1) HRP20140280T1 (https=)
PL (1) PL2117525T3 (https=)
PT (1) PT2117525E (https=)
SI (1) SI2117525T1 (https=)
WO (1) WO2008110323A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2582366T1 (sl) * 2010-06-15 2016-02-29 Gruenenthal Gmbh Farmacevtska kombinacija za zdravljenje bolečine
EP3597628A1 (en) * 2010-07-23 2020-01-22 Grünenthal GmbH Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
WO2012051246A1 (en) 2010-10-12 2012-04-19 Ratiopharm Gmbh Tapentadol hydrobromide and crystalline forms thereof
JP2019142972A (ja) * 2011-03-04 2019-08-29 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
RS56692B1 (sr) * 2011-03-04 2018-03-30 Gruenenthal Gmbh Polučvrsta vodena farmaceutska kompozicija koja sadrži tapentadol
CA2828635C (en) * 2011-03-04 2020-01-14 Grunenthal Gmbh Parenteral administration of tapentadol
KR101946790B1 (ko) 2011-03-04 2019-02-13 그뤼넨탈 게엠베하 경구 투여를 위한 타펜타돌의 수성 약제학적 제형
US20120309840A1 (en) 2011-04-05 2012-12-06 Gruenenthal Gmbh Treatment of Pain Associated with Trigeminal Neuralgia
RS58064B1 (sr) 2011-04-05 2019-02-28 Gruenenthal Gmbh Tapentadol za sprečavanje hronifikacije bola
LT3272343T (lt) 2011-04-29 2020-05-11 Grünenthal GmbH Tapentadolis, skirtas depresijos ir nerimo prevencijai ir gydymui
EP2736501B1 (en) * 2011-07-29 2017-12-20 Grünenthal GmbH Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol
US8853393B2 (en) 2011-07-29 2014-10-07 Anhui New Star Pharmaceutical Development Co., Ltd. Intermediate for preparing tapentadol or analogues thereof
CN103159633B (zh) * 2012-07-06 2015-08-12 江苏恩华药业股份有限公司 他喷他多的制备方法及用于制备他喷他多的化合物
EP2808319A1 (en) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
EP3273953B1 (en) 2015-03-27 2019-01-02 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
CN109996533A (zh) 2016-09-23 2019-07-09 格吕伦塔尔有限公司 用于肠胃外施用他喷他多的稳定制剂
WO2018153947A1 (en) 2017-02-23 2018-08-30 Grünenthal GmbH Tapentadol as local anesthetic
CN114788814B (zh) * 2021-01-26 2023-10-13 浙江创新生物有限公司 一种高稳定性的注射用达托霉素组合物及其制备方法和其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PT1562567T (pt) * 2002-11-22 2017-08-24 Gruenenthal Gmbh Combinação de analgésicos selecionados e inibidores da cox-ii
RU2442576C2 (ru) * 2006-04-28 2012-02-20 Грюненталь Гмбх Фармацевтическая комбинация, содержащая 3-(3-диметиламино-1-этил-2-метилпропил)фенол и парацетамол

Also Published As

Publication number Publication date
US8536130B2 (en) 2013-09-17
JP6081337B2 (ja) 2017-02-15
JP6745959B2 (ja) 2020-08-26
WO2008110323A1 (de) 2008-09-18
PL2117525T3 (pl) 2014-05-30
HRP20140280T1 (hr) 2014-04-25
PT2117525E (pt) 2014-02-14
JP2019196405A (ja) 2019-11-14
JP2010520907A (ja) 2010-06-17
CY1115455T1 (el) 2017-01-04
US20100311842A1 (en) 2010-12-09
JP2016056188A (ja) 2016-04-21
EP2117525A1 (de) 2009-11-18
US20080269326A1 (en) 2008-10-30
JP2018030886A (ja) 2018-03-01
ES2452830T3 (es) 2014-04-02
CA2680771C (en) 2015-11-17
JP2013256540A (ja) 2013-12-26
SI2117525T1 (sl) 2014-03-31
CA2680771A1 (en) 2008-09-18
DE102007012165A1 (de) 2008-09-18
EP2117525B1 (de) 2013-12-25

Similar Documents

Publication Publication Date Title
DK2117525T3 (da) Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte
DK3289876T3 (da) Forbindelser til behandling af cancer
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
DK2240130T3 (da) Indretning til behandling af fedme
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
DK2307042T3 (da) Modulering af trpv: vps10p-domænereceptorsystem til behandlingen af smerte
DK2498771T3 (da) Anvendelse af bethanechol til behandling af xerostomi
DK2478907T3 (da) Sammensætninger til behandling af kræft
DK2047870T3 (da) Indretning til fotokatalytisk behandling af fluider
BRPI0811265A2 (pt) Tratamento de sinucleinopatias
DK2500047T3 (da) Lægemiddelfrigivende coatinger til medicinske indretninger
DK2209900T3 (da) Anvendelse af bakterier til fremstillingen af bioenergi
DK2346321T4 (da) Sammensætning til forbedring af effektiviteten af herbicider
DK2167095T3 (da) Phenothiazin-forbindelser til behandling af let kognitiv svækkelse
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK2114386T3 (da) Farmaceutisk sammensætning til behandling af diabeteskomplikationer
BRPI0820677A2 (pt) Misturas de compostos pesticidas
PL2205720T3 (pl) Kompozycja do leczenia stwardnienia rozsianego
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme